共 50 条
- [31] The Impact of Smoking on Clinical Outcomes and the Role of Double-Dose versus Standard-Dose Clopidogrel Among Individuals With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention -Insights From the CURRENTOASIS 7 TrialCIRCULATION, 2016, 134Bossard, MatthiasAl Khdair, DararFaxon, David P.Granger, Christopher B.Jolly, SanjitNatarajan, MadhuTanguay, Jean-FrancoisSteg, GabrielMontalescot, GillesWidimsky, PetrNiemela, KariGao, PeggyFox, Keith A.Yusuf, SalimMehta, Shamir R.
- [32] Platelet reactivity and clinical outcomes in acute coronary syndrome patients treated with prasugrel and clopidogrel: a pre-specified exploratory analysis from the TROPICAL-ACS trialEUROPEAN HEART JOURNAL, 2019, 40 (24) : 1942 - +Aradi, DanielGross, LisaTrenk, DietmarGeisler, TobiasMerkely, BelaKiss, Robert GaborKomocsi, AndrasDezsi, Csaba AndrasRuzsa, ZoltanUngi, ImreRizas, Konstantinos D.May, Andreas E.Muegge, AndreasZeiher, Andreas M.Holdt, LescaHuber, KurtNeumann, Franz-JosefKoltowski, LukaszHuczek, ZenonHadamitzky, MartinMassberg, SteffenSibbing, Dirk
- [33] Stroke Outcomes With Vorapaxar Versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER TrialJOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (24):Ungar, LeoClare, Robert M.Rodriguez, FatimaKolls, Bradley J.Armstrong, Paul W.Aylward, PhilipHeld, ClaesMoliterno, David J.Strony, JohnVan de Werf, FransWallentin, LarsWhite, Harvey D.Tricoci, PierluigiHarrington, Robert A.Mahaffey, Kenneth W.Melloni, Chiara
- [34] Stroke Outcomes With Vorapaxar versus Placebo in Patients With Acute Coronary Syndromes: Insights From the TRACER TrialCIRCULATION, 2018, 138Ungar, LeoClare, RobertRodriguez, FatimaKolls, BradleyArmstrong, PaulAylward, PhilipHeld, ClaesMoliterno, DavidStrony, JohnVan de Werf, FransWallentin, LarsWhite, HarveyTricoci, PierluigiHarrington, RobertMahaffey, KennethMelloni, Chiara
- [35] Association Between Very Low Levels of High-Density Lipoprotein Cholesterol and Long-term Outcomes of Patients With Acute Coronary Syndrome Treated Without Revascularization: Insights From the TRILOGY ACS TrialCLINICAL CARDIOLOGY, 2016, 39 (06) : 329 - 337Hagstrom, EmilRoe, Matthew T.Hafley, GailNeely, Megan L.Sidhu, Mandeep S.Winters, Kenneth J.Prabhakaran, DorairajWhite, Harvey D.Armstrong, Paul W.Fox, Keith A. A.Ohman, MagnusBoden, William E.
- [36] Invasive versus medically managed acute coronary syndromes with prior bypass (CABG-ACS): insights into the registry versus randomised trial populationsOPEN HEART, 2021, 8 (01):Lee, Matthew M. Y.Petrie, Mark C.Rocchiccioli, PaulSimpson, JoanneJackson, Colette E.Corcoran, David S.Mangion, KennethBrown, AmmaniCialdella, PioSidik, Novalia P.McEntegart, Margaret B.Shaukat, AadilRae, Alan P.Hood, Stuart H. M.Peat, Eileen E.Findlay, Iain N.Murphy, Clare L.Cormack, Alistair J.Bukov, Nikolay B.Balachandran, Kanarath P.Ford, IanWu, OliviaMcConnachie, AlexBarry, Sarah J. E.Berry, Colin
- [37] Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trialLANCET, 2013, 382 (9892): : 605 - 613Wiviott, Stephen D.White, Harvey D.Ohman, E. MagnusFox, Keith A. A.Armstrong, Paul W.Prabhakaran, DorairajHafley, GailLokhnygina, YuliyaBoden, William E.Hamm, ChristianClemmensen, PeterNicolau, Jose C.Menozzi, AlbertoRuzyllo, WitoldWidimsky, PetrOto, AliLeiva-Pons, JosePavlides, GregoryWinters, Kenneth J.Roe, Matthew T.Bhatt, Deepak L.
- [38] Impact of Coronary Calcification in Patients Presenting With Acute Coronary Syndromes: Insights From the MATRIX trialJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B74 - B75Sanchez, Jorge SanzGarcia-Garcia, HectorLeonardi, SergioCalabro, PaoloBriguori, CarloLimbruno, UgoGarbo, RobertoRusso, FilippoLupi, AlessandroEsposito, GiuseppePresbitero, PatriziaSantarelli, AndreaSardella, GennaroVarbella, FerdinandoTresoldi, SimoneDe Cesare, NicolettaBoccuzzi, GiacomoOmerovic, ElmirHeg, DikVranckx, Pascal
- [39] Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: The TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trialAMERICAN HEART JOURNAL, 2010, 160 (01) : 16 - U35Chin, Chee TangRoe, Matthew T.Fox, Keith A. A.Prabhakaran, DorairajMarshall, Debra A.Petitjean, HeleneLokhnygina, YuliyaBrown, EileenArmstrong, Paul W.White, Harvey D.Ohman, E. Magnus
- [40] Frailty is associated with worse outcomes in non-ST-segment elevation acute coronary syndromes: Insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trialEUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2016, 5 (03) : 231 - 242White, Harvey D.Westerhout, Cynthia M.Alexander, Karen P.Roe, Matthew T.Winters, Kenneth J.Cyr, Derek D.Fox, Keith A. A.Prabhakaran, DorairajHochman, Judith S.Armstrong, Paul W.Ohman, E. Magnus